CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Unconventional CD8+ TCRγβ+ T cells were increased 3.6-fold in patients On TKI in comparison with healthy donors and patients with new diagnosis of CML, still untreated (Figure 4B, left graph).